February is American Heart Month. And what better time to talk about heart health? Did you know heart disease claims a life ...

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment ...

I will admit it - I fell for the promise of diet drinks. A few years ago, when I was trying to get healthier, I switched from ...

A new Georgetown University Medical Center study exploring a new brain imaging technique is bringing stroke experts a step ...

Divorce can be painful for children of separating parents, but new research out of the University of Texas at Arlington ...

A new Georgetown University Medical Center study in collaboration with MedStar Health and the National Institutes of Health exploring a new brain imaging technique is bringing stroke experts a step ...

Older adults who are admitted to the hospital with their first ischemic stroke who have poor nutritional status upon admission have a higher risk of post-stroke myocardial injury, a study shows.

Johnson & Johnson MedTech issued a recall for its Biosense Webster Varipulse Bi-Directional Ablation Catheter following reports of strokes and transient ischemic attacks in patients undergoing ...

FDA approval was based on the AcT noninferiority trial that found tenecteplase (at 0.25 mg/kg) to be at least on par with alteplase for safety and efficacy in acute ischemic stroke in Canadians ...

From a certain high-heeled Mouse to the tiny version of our favorite candy, just the idea of "mini" is psychologically ...

In recognition of Brain Health Awareness Week, which runs from March 10-16, Jamaica Hospital Medical Center Neurosurgeon Dr.

Genentech has had the lone medicine on the market for the acute treatment of stroke. | Over nearly the last three decades, ...